title: Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibody.
authors.affiliation: Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
authors.forename: R
authors.initials: R
authors.lastname: Ahlberg
authors.forename: Q
authors.initials: Q
authors.lastname: Yi
authors.forename: R
authors.initials: R
authors.lastname: Pirskanen
authors.forename: G
authors.initials: G
authors.lastname: Matell
authors.forename: C
authors.initials: C
authors.lastname: Swerup
authors.forename: P
authors.initials: P
authors.lastname: Rieber
authors.forename: G
authors.initials: G
authors.lastname: Riethmüller
authors.forename: G
authors.initials: G
authors.lastname: Holm
authors.forename: A K
authors.initials: AK
authors.lastname: Lefvert
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D016131:Lymphocyte Subsets / Q000276:immunology; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000628:therapy*; D011993:Recombinant Fusion Proteins
chemical_list: D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D011993:Recombinant Fusion Proteins